97 related articles for article (PubMed ID: 8730454)
1. Significance of serum fibrin/fibrinogen degradation products measured by a highly sensitive ELISA method in renal diseases.
Shibata T; Magari Y; Perparim K; Yasumori R; Nasu M
Nephron; 1996; 72(4):717-8. PubMed ID: 8730454
[No Abstract] [Full Text] [Related]
2. Urinary fibrin/fibrinogen degradation product E (FDP-E) measured by a highly sensitive ELISA method in renal diseases.
Shibata T; Magari Y; Mizunaga S; Ishii T; Tomo T; Yasumori R; Nasu M; Taguchi T
Nephron; 1998 Aug; 79(4):494-5. PubMed ID: 9689177
[No Abstract] [Full Text] [Related]
3. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
Kacprzyk F; Orłowski Z
Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
[No Abstract] [Full Text] [Related]
4. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
[No Abstract] [Full Text] [Related]
5. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen-fibrin degradation products in renal disorders.
Dube B; Srivastava PK; Padmanabhan R; Dube RK
Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
[No Abstract] [Full Text] [Related]
7. [Glomerular fibrins, serum and urinary FDP fragments in kidney diseases in children].
Uetsuji H; Taira K
Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):826-9. PubMed ID: 6663849
[No Abstract] [Full Text] [Related]
8. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
9. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a test for soluble fibrin polymer (TpP) with a standard quantitative ELISA for D-dimer in patients, without current thrombosis, who have cancer or renal disease.
Arkel YS; Ku DH; Le P; Carr AM
Thromb Haemost; 2001 Oct; 86(4):1127-8. PubMed ID: 11686342
[No Abstract] [Full Text] [Related]
11. Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination.
Proietti AB; Johnson MJ; Proietti FA; Repke JT; Bell WR
Obstet Gynecol; 1991 May; 77(5):696-700. PubMed ID: 2014082
[TBL] [Abstract][Full Text] [Related]
12. [The detection of serum and urine fibrin and fibrinogen degradation products by hemagglutination inhibition test (author's transl)].
Wang Z
Zhonghua Nei Ke Za Zhi; 1979; 18(5):330-3. PubMed ID: 555935
[No Abstract] [Full Text] [Related]
13. [Study of blood and urinary FDP fragments in patients with renal disease].
Taura K
Nihon Jinzo Gakkai Shi; 1983 Mar; 25(3):245-56. PubMed ID: 6887631
[No Abstract] [Full Text] [Related]
14. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
[TBL] [Abstract][Full Text] [Related]
15. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
16. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
Nakamichi S
Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
[No Abstract] [Full Text] [Related]
17. [The usefullness of the fibrinogen degradation products (FDP) determination in the serum and urine in diagnostics and evaluation of effectiveness of therapy of nephropathy (author's transl)].
Kwiecien-Głowacka E
Przegl Lek; 1981; 38(3):335-40. PubMed ID: 7244292
[No Abstract] [Full Text] [Related]
18. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
[No Abstract] [Full Text] [Related]
19. [Clinical diagnosis of blood coagulation in the kidney glomerulus].
Taura K; Harada K
Nihon Jinzo Gakkai Shi; 1983 Jul; 25(7):829-31. PubMed ID: 6663850
[No Abstract] [Full Text] [Related]
20. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
